News Chart Incyte Corporation

Stocks

INCY

US45337C1027

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 18:11:52 20/07/2026 BST			5-day change	1st Jan Change
115.73 ^USD	-1.30%		+1.37%	+17.24%

02:09pm	Halozyme Therapeutics, Incyte Sign Deal to Develop Subcutaneous Formulations of Blood Cancer Drug	MT
01:47pm	Goldman Sachs Adjusts Price Target on Incyte to $110 From $100, Maintains Neutral Rating	MT

2f9bdf7739fc54ec0fe3d.lPAGMUCzzcPBwGvA9Hd6xU4chqdx0HLoghuzUGsgSko.oLJuHCv7l5evpiqEsj0bljRz7uhHvgSj43zQMz9lcw_Dt3JoEPf7lPDwIg~3fd73209943f78e01a88279d6c3d2f92